Researchers at USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, have launched a clinical trial to ...

Wee1 inhibitors are a promising new cancer treatment, but serious side effects threaten their adoption in the clinic. Now, ...

NeOnc is scheduled to meet with the FDA on November 17, 2026, for an in-person End-of-Phase 1 Type B meeting concerning NEO212, its separate investigational oral program. The company intends to ...

That Hurricane Isaias didn’t ruin more lives or property is not because Florida got smarter about predicting windstorms. It’s ...

AdventHealth hosts free wellness events SEBRING – Hundreds of residents across Highlands and Hardee counties participated in AdventHealth’s Day of Wholeness on Oct. 17, featuring free health ...

Researchers engineered hybrid strontium sulfite nanoparticle-modified lipid nanoparticles to deliver p53 mRNA, producing ...

Danielle Ripley-Burgess ignored blood in her stool for three years as a teenager — then was diagnosed with stage 3 colon ...

New reports help medical affairs teams connect published research to real-world outcomes, including clinical guidelinesTokyo, Japan and London, United Kingdom--(Newsfile Corp. - October 20, 2026) - ...

Background The role of intrinsic tumour heterogeneity in driving organ-tropic metastasis in gastric cancer remains ...

From October 19 to 23, the Gairdner Foundation presents Gairdner Science Week 2026, bringing together scientists, students, ...

Premier sponsorship of the HERmedicine and OncoMenopause Consortium® program underscores Daré Bioscience's commitment to ...

In addition to its sponsorship of the HERmedicine and OncoMenopause Consortium program, Daré Bioscience will participate in ...